• Prednisolone in Synthetic Glucocorticoid Signaling Workflows

  2026-06-15

  Prednisolone, a synthetic glucocorticoid, is pivotal in advanced immunology research—enabling reproducible glucocorticoid signaling assays and inflammation modulation studies. Harnessing high-purity Prednisolone from APExBIO ensures robust, scalable protocols for dissecting cellular responses and troubleshooting experimental challenges.

• OM-MSCs Mitigate Golgi Stress Post-Stroke via PI3K/Akt/mTOR

  2026-06-15

  This study reveals that olfactory mucosa mesenchymal stem cells (OM-MSCs) alleviate Golgi apparatus stress responses after cerebral ischemia/reperfusion injury by activating the PEDF–PI3K/Akt/mTOR pathway. The findings highlight a novel neuroprotective mechanism and suggest new directions for targeting Golgi-mediated stress in stroke models.

• N-octanoyl-L-Homoserine lactone in Microbial Pathogenicity R

  2026-06-14

  N-octanoyl-L-Homoserine lactone (C8-HSL) is transforming infection biology and cancer risk research by enabling precise modeling of quorum-sensing-driven pathogenicity. This guide details cutting-edge workflows, experimental optimizations, and actionable troubleshooting tips for leveraging C8-HSL in translational studies, with direct connections to recent breakthroughs in cancer–microbiota interactions.

• Gly-Gly-Phe-Gly (GGFG) Peptide: Transforming Drug Conjugatio

  2026-06-13

  Gly-Gly-Phe-Gly (GGFG) stands out as a flexible peptide linker, streamlining bioconjugation and peptide engineering for advanced drug delivery. Learn how high-purity GGFG from APExBIO enables reproducible, optimized workflows in antibody-drug conjugate development, with evidence-based troubleshooting and protocol insights.

• MK 0893: Strategic Guidance for Translational Diabetes Resea

  2026-06-12

  This thought-leadership article provides translational researchers with a mechanistic deep dive and strategic roadmap for leveraging MK 0893, a benchmark glucagon receptor antagonist, in type 2 diabetes workflows. Incorporating new findings from indazole-/indole-based antagonist research and referencing APExBIO’s product intelligence, it delivers advanced protocol guidance, competitive context, and future-facing insights—promoting confident experimental design and clinical translation.

• GRK Subtype Bias in M1 Acetylcholine Receptor Signaling Mech

  2026-06-12

  This study elucidates how distinct GRK subtypes differentially regulate biased signaling downstream of the M1 muscarinic acetylcholine receptor, with direct implications for cognitive function modulation and Alzheimer's disease research. Quantitative BRET assays reveal that positive allosteric modulators such as BQCA can selectively potentiate M1 receptor signaling, offering a clearer blueprint for safer and more effective therapeutic targeting.

• Nicotinamide Adenine Dinucleotide (NAD+): Optimizing Stress

  2026-06-11

  APExBIO’s high-purity NAD+ empowers stress adaptation research by enabling precise modulation of metabolic and DNA repair pathways. Learn how to design, troubleshoot, and enhance advanced cellular assays using NAD+ to interrogate autophagy and cytoprotective responses in cancer models.

• Hemagglutinin mRNA Vaccine Confers Lasting H5N1 Protection i

  2026-06-11

  This study demonstrates that a hemagglutinin-based mRNA–lipid nanoparticle vaccine induces robust, long-lasting protection against H5N1 influenza in lactating dairy cows. The findings mark an advance in veterinary mRNA vaccine design and inform strategies for zoonotic influenza control.

• Tunable Human Intestinal Organoids: Balancing Self-Renewal a

  2026-06-10

  This study presents a tunable human intestinal organoid system that achieves a controlled balance between stem cell self-renewal and differentiation using small molecule pathway modulators. The innovation enables maintenance of proliferative capacity alongside increased cellular diversity, improving scalability for high-throughput applications and addressing major limitations of conventional organoid culture platforms.

• Amikacin (BAY416651): Protocols & Innovations in Resistance

  2026-06-10

  Amikacin (BAY416651) distinguishes itself as a semi-synthetic aminoglycoside antibiotic, combining robust resistance to modifying enzymes with proven utility in advanced antibiotic resistance workflows. This article details hands-on protocols and troubleshooting for high-impact studies, including targeted drug delivery to granulomas and resistance mechanism assays.

• Plant Cell Lysis Buffer for WB and IP: Optimizing Protein Ex

  2026-06-09

  Unlock precise, non-denaturing protein extraction from plant samples with APExBIO's Plant Cell Lysis Buffer for WB and IP. This guide translates the latest MAPK10/KRT16 research into actionable workflows for Western blotting and immunoprecipitation, featuring protocol enhancements and troubleshooting strategies for high-integrity sample preparation.

• Epidermal Growth Factor: Applied Workflows and Troubleshooti

  2026-06-09

  Harness recombinant human EGF for precise control over cell proliferation, differentiation, and mucosal healing. This article details optimized workflows, advanced applications, and troubleshooting insights, empowering researchers to maximize data quality and reproducibility with APExBIO’s rigorously validated EGF.

• Cleavage-Resistant TREM2 Enhances Macrophage Efferocytosis i

  2026-06-08

  Dong et al. engineered a synthetic, cleavage-resistant TREM2 receptor that resists ADAM17-mediated shedding, enabling sustained efferocytosis by macrophages in inflammatory settings. Their approach demonstrates reduced apoptotic cell accumulation and inflammation in mouse models, signaling a potential advance for treating diseases characterized by impaired cell clearance.

• NPT1 Mediates Renal Apical Transport of Faropenem and Relate

  2026-06-08

  This study demonstrates that the human inorganic phosphate transporter NPT1 functions as an organic anion transporter at the renal apical membrane, mediating transport of p-aminohippuric acid, faropenem, and other anionic compounds. The findings clarify a previously unknown molecular mechanism for renal drug secretion, informing antibiotic pharmacokinetics and translational research.

• Sisomicin’s In Vitro Potency and Its Relevance for Aminoglyc

  2026-06-07

  The reference study presents a comprehensive assessment of sisomicin’s antimicrobial spectrum and potency against clinical isolates, highlighting its higher efficacy compared to kanamycin and butirosin, and its close similarity to gentamicin and tobramycin. These findings inform ongoing antibiotic resistance research and offer a benchmark for the use and evaluation of aminoglycoside antibiotics in microbiology workflows.

413 records 12/28 page Previous Next First page 上5页 1112131415 下5页 Last page